Volume 8 Issue 3
May  2017
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2017  >  8(3): 195-199
Yang Zhenkun, Li Huixing, Wang Wei, et al. Effect of azitromycin on Th17/Treg balance in bronchiolitis obliterans mice after lung transplantation[J]. ORGAN TRANSPLANTATION, 2017, 8(3): 195-199. doi: 10.3969/j.issn.1674-7445.2017.03.004
Citation: Yang Zhenkun, Li Huixing, Wang Wei, et al. Effect of azitromycin on Th17/Treg balance in bronchiolitis obliterans mice after lung transplantation[J]. ORGAN TRANSPLANTATION, 2017, 8(3): 195-199. doi: 10.3969/j.issn.1674-7445.2017.03.004
shu

Effect of azitromycin on Th17/Treg balance in bronchiolitis obliterans mice after lung transplantation

doi: 10.3969/j.issn.1674-7445.2017.03.004

  • Jiangsu Key Laboratory of Human Organ Transplantation, Wuxi 214023, China

More Information
  • Corresponding author: Chen Jingyu, Email: chenjingyu333@sina.com
  • Received Date: 2017-02-15
    Available Online: 2021-01-19
  • Publish Date: 2017-05-15
    Abstract
  •   Objective   To evaluate the effect of azitromycin upon the bronchiolitis obliterans and T helper (Th)17/regulatory T cell (Treg) balance after lung transplantation.   Methods   Twenty-four specific pathogen free(SPF) C57BL/6 mice were used as the donors and 48 Balb/c mice were utilized as the recipients. The Balb/c mice were randomly divided into the control (C group), azitromycin control (Cazm group), transplantation (T group) and transplantation + azitromycin groups (Tazm group), 12 mice in each group. In the T and Tazm groups, heterotopic tracheal transplantation models were established to simulate bronchiolitis obliterans after lung transplantation. From 1 d post-transplantation, intragastric administration of azitromycin was given at a dose of 30 mg/kg three times per week in the Cazm and Tazm groups. At 14 and 28 d after transplantation, the transplanted trachea was removed and peripheral blood was collected. The tracheal sample was prepared for hematoxylin-eosin (HE) staining for pathological observation. The expression levels of ROR-t and Foxp3 messenger ribonucleic acid (mRNA) in the peripheral blood were quantitatively measured by reverse transcription polymerase chain reaction (RT-PCR). The variation in the related cytokines levels of Th17 cells and Treg in the plasma was detected by enzyme linked immunosorbent assay (ELISA).   Results   After heterotopic tracheal transplantation, compared with the C group, the tracheal occlusion accompanied with inflammatory infiltration was observed in the T and Tazm groups. The severity of relevant symptoms in the Tazm group was slighter than that in the T group. Compared with the T group, the expression level of ROR-γt mRNA in the Tazm group was significantly down-regulated (P < 0.05). No statistical significance was identified in the expression of Foxp3 mRNA between two groups (P>0.05). Compared with the T group, the levels of interleukin (IL)-6 and IL-17 cytokines in the Tazm group were significantly down-regulated (all P < 0.05).   Conclusion   Persistent therapy of azitromycin can delay the progression of bronchiolitis obliterans after transplantation, which is probably associated with inhibiting Th17 cell differentiation and inflammation.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    Benden C, Goldfarb SB, Edwards LB, et al. The registry of the international society for heart and lung transplantation: seventeenth official pediatric lung and heart-lung transplantation report--2014; focus theme: retransplantation[J]. J Heart Lung Transplant, 2014, 33(10):1025-1033. DOI: 10.1016/j.healun.2014.08.005.
    [2]
    Jain R, Hachem RR, Morrell MR, et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome[J]. J Heart Lung Transplant, 2010, 29(5):531-537. DOI: 10.1016/j.healun.2009.12.003.
    [3]
    Corris PA, Ryan VA, Small T, et al.A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation[J].Thorax, 2015, 70(5):442-450. DOI: 10.1136/thoraxjnl-2014-205998.
    [4]
    Scheffert JL, Raza K. Immunosuppression in lung transplantation[J]. J Thorac Dis, 2014, 6(8):1039-1053. DOI: 10.3978/j.issn.2072-1439.2014.04.23.
    [5]
    Martin-Gandul C, Mueller NJ, Pascual M, et al. The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation[J]. Am J Transplant, 2015, 15(12):3024-3040. DOI: 10.1111/ajt.13486.
    [6]
    Lin SJ, Kuo ML, Hsiao HS, et al. Azithromycin modulates immune response of human monocyte-derived dendritic cells and CD4+ T cells [J]. Int Immunopharmacol, 2016, 40:318-326. DOI: 10.1016/j.intimp.2016.09.012.
    [7]
    Federica M, Nadia S, Monica M, et al. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection [J]. Clin Transplant, 2011, 25(4):E381-E389. DOI: 10.1111/j.1399-0012.2011.01435.x.
    [8]
    Vos R, Vanaudenaerde BM, Verleden SE, et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation [J]. Eur Respir J, 2011, 37(1):164-172. DOI: 10.1183/09031936.00068310.
    [9]
    Vos R, Verleden SE, Ruttens D, et al. Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation [J]. Am J Transplant, 2014, 14(12):2736-2748. DOI: 10.1111/ajt.12942.
    [10]
    Pain M, Royer PJ, Loy J, et al. T cells promote bronchial epithelial cell secretion of matrix metalloproteinase-9 via a C-C chemokine receptor type 2 pathway: implications for chronic lung allograft dysfunction [J]. Am J Transplant, 2016, DOI: 10.1111/ajt.14166 [Epub ahead of print].
    [11]
    Tao JH, Cheng M, Tang JP, et al. Foxp3, regulatory T cell, and autoimmune diseases [J]. Inflammation, 2017, 40(1):328-339. DOI: 10.1007/s10753-016-0470-8.
    [12]
    Huang W, Littman DR. Regulation of RORγt in inflammatory lymphoid cell differentiation [J]. Cold Spring Harb Symp Quant Biol, 2015, 80:257-263. DOI: 10.1101/sqb.2015.80.027615.
    [13]
    Astry B, Venkatesha SH, Moudgil KD. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis [J]. Cytokine, 2015, 74(1):54-61. DOI: 10.1016/j.cyto.2014.11.020.
    [14]
    Hong SC, Lee SH. Role of Th17 cell and autoimmunity in chronic obstructive pulmonary disease [J]. Immune Netw, 2010, 10(4):109-114. DOI: 10.4110/in.2010.10.4.109.
    [15]
    ager A, Kuchroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation[J].Scand J Immunol, 2010, 72(3):173-184. DOI: 10.1111/j.1365-3083.2010.02432.x.
    [16]
    Fan L, Benson HL, Vittal R, et al. Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation[J]. Am J Transplant, 2011, 11(5):911-922. DOI: 10.1111/j.1600-6143.2011.03482.x.
    [17]
    Verleden SE, Vos R, Vandermeulen E, et al. Involvement of interleukin-17 during lymphocytic bronchiolitis in lung transplant patients [J]. J Heart Lung Transplant, 2013, 32(4):447-453. DOI: 10.1016/j.healun.2012.12.016.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (82) PDF downloads(8) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return